Overcoming Resistance to Targeted Therapies in Gastrointestinal Cancers: Progress to Date and Progress to Come.

Targeted therapies have transformed the treatment paradigm in diseases such as non–small cell lung cancer and melanoma but have shown relatively modest clinical benefit in gastrointestinal malignan...